| Name | Department | Institution | Website | Project Title |
| James Bibb | Psychiatry
| University of Arizona
| James A. Bibb, Ph.D. | Study and Treatment of Chronic Disease Caused by Convergent Substance Use Disorder, Inflammation, and Metabolic Dysregulation |
| Thomas Biederer | Neurology | Yale University | Thomas Biederer, Ph.D.
| Identification and Analysis of Synapse-Organizing Complexes in Addiction-Relevant Brain Regions
|
| Kristen Brennand | Psychiatry | Yale University | Kristen Brennand, Ph.D. | Impact of Patient-Specific Perturbations in the NRXN1a Isoform Repertoire on Synaptic Composition
|
| Sreeganga Chandra | Neurology | Yale University | Sreeganga Chandra, Ph.D. | Neuronal Substrates Required for Synapse Maintenance |
Christopher Cowan
| Neuroscience, Psychiatry
| Medical University of South Carolina
| Christopher Cowan, Ph.D.
| Identification of Protein Complexes Regulating Prepotent Drug-cue Associations and Relapse-like Behavior in Preclinical Models of SUD
|
| Pietro De Camilli | Cell Biology, Neuroscience | Yale University | Pietro De Camilli, M.D. | Membrane Traffic and Lipid Dynamics in Neuronal Function
|
Christie Fowler
| Neurobiology and Behavior
| University of California, Irvine
| Christie Fowler, Ph.D.
| Proteomic Analysis of the Impact of Nicotine and THC on Extracellular Vesicle Signaling
|
| Matthew Girgenti | Psychiatry
| Yale University
| Matthew Girgenti, Ph.D. | Functional Convergence of Epigenomic and Proteomic Pathways Associated with Cannabis Use and Major Depression |
| William N. Green | Neurobiology | University of Chicago | William N. Green, Ph.D. | Proteomic Assays of Nicotine-induced Golgi Fragments and Changes in Glycosylation
|
Stephanie Groman
| Anesthesia and Critical Care
| University of Chicago
| Stephanie Groman, Ph.D.
| Protein Mechanisms of Drug Use Susceptibility
|
Yasmin Hurd
| Pharmacological Sciences, Neuroscience, Psychiatry
| Icahn School of Medicine at Mount Sinai
| Yasmin Hurd, PH.D.
| Proteomic Analysis of Neural Epigenetic Mechanisms and Immune System Underlying Long-Lasting Effects of Developmental Cannabis Exposure |
| Leonard K. Kaczmarek | Pharmacology, Cellular and Molecular Physiology | Yale University | Leonard K. Kaczmarek, Ph.D. | Modulation of Potassium Channels by Protein Phosphorylation and Interacting Auxiliary Proteins
|
| Paul J. Kenny | Pharmacology, and Systems Therapeutics | Icahn School of Medicine at Mount Sinai | Paul J. Kenny, Ph.D. | Mechanisms by Which Tcf7l2 Controls Addiction-relevant Gene Expression in the Habenula
|
Drew Kiraly
| Psychiatry, Neuroscience
| Wake Forest University
| Drew Kiraly, M.D.; Ph.D.
| Neuroimmune and Microbiome Effects on Limbic Reward Structures in Models of Substance Use Disorders
|
| Michael R. Koelle | Molecular Biophysics & Biochemistry | Yale University
| Michael R. Koelle, Ph.D. | Proteomic Analysis of Complexes formed by the Neural G Protein Gao |
Ryan Logan
| Pharmacology & Experimental Therapeutics
| University of Massachusetts
| Ryan Logan, Ph.D.
| The Impact of Morphine on the Diurnal Variation of Protein Expression in the Dorsal Striatum |
| Ken Loh | Comparative Medicine
| Yale University
| Ken Huaijin Loh, PhD
| Developing New Proximity Labeling Methodologies to Study Neuronal Signaling |
| Hui-Chen Lu | Psychological & Brain Sciences | Indiana University at Bloomington | Hui-Chen Lu, Ph.D. | Mechanisms and Treatment of Adolescent Phytocannabinoid Impairment of Prefrontal Cortex Function |
| Ken Mackie | Psychological and Brain Sciences | Indiana University | Ken Mackie, M.D. | Effects of Phytocannabinoids on the Developing Cerebellum
|
| Angus Nairn | Psychiatry | Yale University | Angus Nairn, Ph.D. | Regulation of Synaptic Structure and Function by Drugs of Abuse |
| Eric Nestler | Neuroscience | Icahn School of Medicine at Mount Sinai | Eric Nestler, Ph.D., M.D.
| Proteomic Profiling of Drug-induced Alterations to the Brain Reward System Underlying Addiction
|
| Marina Picciotto | Psychiatry, Pharmacology, Neurobiology | Yale University | Marina Picciotto, Ph.D. | Proteomics of Altered Signaling in Nicotine Addiction
|
Paul Slesinger
| Neuroscience
| Icahn School of Medicine at Mount Sinai
| Paul Slesinger, Ph.D.
| Characterization of Changes in the GIRK Channel Proteome with Psychostimulants
|
| Stephen Strittmatter | Neurobiology, Neurology
| Yale University | Stephen Strittmatter, M.D., Ph.D. | Proteomic Basis for Chronic Anatomical Plasticity of Synapses |
| Jane Taylor | Psychiatry | Yale University | Jane Taylor, Ph.D. | Proteomic Analysis of Cellular Alterations Associated with Drug-Induced Impairments in Decision-Making, Mnemonic Processes and Relapse Behaviors |
| Susumu Tomita | Cellular and Molecular Physiology
| Yale University | Susumu Tomita, Ph.D. | Identification of Altered Phosphorylation Signaling in Neurotransmission
|
| Mary Torregrossa | Psychiatry | University of Pittsburgh | Mary Torregrossa, Ph.D. | Identifying Changes in Protein Signaling that Regulate Substance Use Vulnerability, Craving, and Relapse
|